Cargando…
Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
Caffeic acid derivatives containing amide moieties similar to those of finasteride and dutasteride were synthesized. An in vitro inhibitory activity evaluation of caffeic acid (1) and its amide derivatives (2 − 4) against the steroid 5α-reductase type 1 (SRD5A1) produced by human keratinocyte cells...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718795/ https://www.ncbi.nlm.nih.gov/pubmed/36460729 http://dx.doi.org/10.1038/s41598-022-25335-7 |
_version_ | 1784843171066281984 |
---|---|
author | Lin, Aye Chan Khine Netcharoensirisuk, Ponsawan Sanachai, Kamonpan Sukma, Warongrit Chansriniyom, Chaisak Chaotham, Chatchai De-Eknamkul, Wanchai Rungrotmongkol, Thanyada Chamni, Supakarn |
author_facet | Lin, Aye Chan Khine Netcharoensirisuk, Ponsawan Sanachai, Kamonpan Sukma, Warongrit Chansriniyom, Chaisak Chaotham, Chatchai De-Eknamkul, Wanchai Rungrotmongkol, Thanyada Chamni, Supakarn |
author_sort | Lin, Aye Chan Khine |
collection | PubMed |
description | Caffeic acid derivatives containing amide moieties similar to those of finasteride and dutasteride were synthesized. An in vitro inhibitory activity evaluation of caffeic acid (1) and its amide derivatives (2 − 4) against the steroid 5α-reductase type 1 (SRD5A1) produced by human keratinocyte cells coupled with the non-radioactive high-performance thin-layer chromatography detection revealed that caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide (4) was a promising non-steroidal suppressor, with a half-maximal inhibitory concentration (IC(50)) of 1.44 ± 0.13 µM and relatively low cytotoxicity with an IC(50) of 29.99 ± 8.69 µM. The regulatory role of compound 4 against SRD5A1 involved both suppression of SRD5A1 expression and mixed mode SRD5A1 inhibition. The K(i) value of compound 4 was 2.382 µM based on the whole-cell kinetic studies under specific conditions. Molecular docking and molecular dynamics simulations with AlphaFold generated the human SRD5A1 structure and confirmed the stability of compound 4 at the SRD5A1 catalytic site with greater interactions, including hydrogen bonding of the key M119 amino-acid residue than those of finasteride and dutasteride. Thus, compound 4 shows the potential for further development as an SRD5A1 suppressor for androgenic alopecia treatment. |
format | Online Article Text |
id | pubmed-9718795 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-97187952022-12-04 Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics Lin, Aye Chan Khine Netcharoensirisuk, Ponsawan Sanachai, Kamonpan Sukma, Warongrit Chansriniyom, Chaisak Chaotham, Chatchai De-Eknamkul, Wanchai Rungrotmongkol, Thanyada Chamni, Supakarn Sci Rep Article Caffeic acid derivatives containing amide moieties similar to those of finasteride and dutasteride were synthesized. An in vitro inhibitory activity evaluation of caffeic acid (1) and its amide derivatives (2 − 4) against the steroid 5α-reductase type 1 (SRD5A1) produced by human keratinocyte cells coupled with the non-radioactive high-performance thin-layer chromatography detection revealed that caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide (4) was a promising non-steroidal suppressor, with a half-maximal inhibitory concentration (IC(50)) of 1.44 ± 0.13 µM and relatively low cytotoxicity with an IC(50) of 29.99 ± 8.69 µM. The regulatory role of compound 4 against SRD5A1 involved both suppression of SRD5A1 expression and mixed mode SRD5A1 inhibition. The K(i) value of compound 4 was 2.382 µM based on the whole-cell kinetic studies under specific conditions. Molecular docking and molecular dynamics simulations with AlphaFold generated the human SRD5A1 structure and confirmed the stability of compound 4 at the SRD5A1 catalytic site with greater interactions, including hydrogen bonding of the key M119 amino-acid residue than those of finasteride and dutasteride. Thus, compound 4 shows the potential for further development as an SRD5A1 suppressor for androgenic alopecia treatment. Nature Publishing Group UK 2022-12-02 /pmc/articles/PMC9718795/ /pubmed/36460729 http://dx.doi.org/10.1038/s41598-022-25335-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Lin, Aye Chan Khine Netcharoensirisuk, Ponsawan Sanachai, Kamonpan Sukma, Warongrit Chansriniyom, Chaisak Chaotham, Chatchai De-Eknamkul, Wanchai Rungrotmongkol, Thanyada Chamni, Supakarn Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics |
title | Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics |
title_full | Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics |
title_fullStr | Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics |
title_full_unstemmed | Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics |
title_short | Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics |
title_sort | caffeic acid n-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718795/ https://www.ncbi.nlm.nih.gov/pubmed/36460729 http://dx.doi.org/10.1038/s41598-022-25335-7 |
work_keys_str_mv | AT linayechankhine caffeicacidn35bistrifluoromethylphenylamideasanonsteroidalinhibitorforsteroid5areductasetype1usingahumankeratinocytecellbasedassayandmoleculardynamics AT netcharoensirisukponsawan caffeicacidn35bistrifluoromethylphenylamideasanonsteroidalinhibitorforsteroid5areductasetype1usingahumankeratinocytecellbasedassayandmoleculardynamics AT sanachaikamonpan caffeicacidn35bistrifluoromethylphenylamideasanonsteroidalinhibitorforsteroid5areductasetype1usingahumankeratinocytecellbasedassayandmoleculardynamics AT sukmawarongrit caffeicacidn35bistrifluoromethylphenylamideasanonsteroidalinhibitorforsteroid5areductasetype1usingahumankeratinocytecellbasedassayandmoleculardynamics AT chansriniyomchaisak caffeicacidn35bistrifluoromethylphenylamideasanonsteroidalinhibitorforsteroid5areductasetype1usingahumankeratinocytecellbasedassayandmoleculardynamics AT chaothamchatchai caffeicacidn35bistrifluoromethylphenylamideasanonsteroidalinhibitorforsteroid5areductasetype1usingahumankeratinocytecellbasedassayandmoleculardynamics AT deeknamkulwanchai caffeicacidn35bistrifluoromethylphenylamideasanonsteroidalinhibitorforsteroid5areductasetype1usingahumankeratinocytecellbasedassayandmoleculardynamics AT rungrotmongkolthanyada caffeicacidn35bistrifluoromethylphenylamideasanonsteroidalinhibitorforsteroid5areductasetype1usingahumankeratinocytecellbasedassayandmoleculardynamics AT chamnisupakarn caffeicacidn35bistrifluoromethylphenylamideasanonsteroidalinhibitorforsteroid5areductasetype1usingahumankeratinocytecellbasedassayandmoleculardynamics |